Medicenna Therapeutics Co... (MDNA)

AI Score

Unlock

0.16

0.00 (1.91%)

At close: Jan 16, 2025, 9:00 PM

Medicenna Therapeutics Cash Flow Statement

Financials in CAD. Fiscal year is April - March.

Fiscal Year	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015
Net Income	-11.58M	-8.76M	-10.05M	-9.4M	-13.06M	-20.35M	-22.58M	-25.18M	-25.72M	-21.32M	-17.29M	-14.16M	-11.22M	-9.33M	-8.28M	-6.64M	-5.97M	-4.96M	-4.71M	-4.97M	-5.43M	-6.25M	-7.47M	-10.51M	-8.33M	-6.63M	-4.39M	-45.3K	-43.68K	-27.01K	-16.63K	-1.08K	-514.23	-285
Depreciation & Amortization	4K	5K	4K	11K	20K	28K	38K	41K	41K	39.92K	40K	33.18K	24.42K	16.73K	7.89K	5.41K	5.88K	6.35K	6.82K	6.82K	6.82K	6.82K	9.7K	9.23K	7.53K	5.83K	1.24K	2.78	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	1.1M	1.26M	1.37M	1.41M	1.49M	1.47M	1.42M	1.45M	1.36M	1.17M	1.01M	1.04M	1.08M	1.1M	1.12M	1.07M	917.25K	953.81K	998.62K	1.24M	1.64M	1.64M	1.62M	1.14M	506.26K	236.29K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	2.47M	1.17M	789.86K	-232.92K	-840.37K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	36.41K	16.78K	16.78K	16.78K	-19.63K	n/a	n/a	n/a	1.36K	-4K	-6.3K	-6.3K	-7.67K	-2.3K	n/a	n/a	n/a
Other Non-Cash Items	-5.28M	-7.44M	-7.59M	-7.44M	-3.98M	-291K	-616K	372K	394K	-234.35K	252K	-15.01K	-40.98K	-41.51K	-1.02M	-2.5M	-3.37M	-4.65M	-5.02M	-5.17M	-6.21M	-5.88M	-4.74M	-1.69M	242.6K	1.22M	1.45M	298.39	170.76	161.43	207.87	207.87	37.11	46.44
Deferred Income Tax	-54K	-54K	1.2M	n/a	n/a	-69K	121K	417K	412K	414.33K	267K	-2.46K	2.54K	117.22K	75.5K	27.08K	172.85K	631.09K	628.15K	873.95K	864.38K	635.17K	951.04K	727.13K	590.92K	313.89K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	2.48M	1.17M	2.41M	2.16M	-848K	-2.18M	-1.84M	480K	3.79M	2.94M	680K	-2.71M	-3.7M	-587.92K	-792.64K	-248.25K	119.31K	393.02K	683.66K	-116.74K	-100.1K	-208.45K	451.44K	1.14M	830.66K	586.65K	130.85K	-7.35K	-7.59K	-21.3K	-5.44K	28.36	35.75	17.88
Operating Cash Flow	-13.34M	-13.82M	-12.66M	-13.26M	-16.38M	-21.32M	-23.58M	-22.85M	-20.13M	-17.41M	-15.31M	-15.82M	-13.85M	-8.85M	-8.95M	-8.31M	-8.3M	-8.26M	-8.04M	-9.01M	-10.09M	-10.69M	-10.12M	-9.91M	-6.74M	-4.58M	-2.81M	-52.34K	-51.11K	-48.14K	-21.87K	-844.34	-441.37	-220.68
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-3.84K	-3.84K	-3.84K	-3.84K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	-10M	-10M	-5M	-5M	-10M	-10M	-15M	-15M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	10.01M	10.01M	20.05M	20.06M	5.05M	5.05M	-4.99M	-5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-195.62K	-195.62K	-195.62K	-195.62K	n/a	n/a	n/a	n/a	608.53K	608.53K	608.53K	608.53K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	10.01M	10.01M	10.05M	10.06M	50K	20.05M	5.01M	-9.83M	-10M	-30M	-15M	-365.72K	-195.62K	-195.62K	-195.62K	-140.03K	-140.03K	-140.03K	-140.03K	604.69K	604.69K	604.69K	604.69K	0.00	1.2K	1.2K	1.2K	1.2K	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	-189	-189	-189	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-886.77	-886.77	-886.77	-886.77	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-53K	23.79M	24.76M	25.03M	28.37M	4.59M	3.88M	13.38M	13.01M	13.13M	18.26M	41.9M	46.04M	48.41M	44.28M	11.06M	9.06M	8.08M	6.82M	7.25M	1.84M	267.39K	310.39K	10.44M	11.37M	11.51M	11.47M	913.23K	145.4K	3.83K	4.59K	4.59K	1.52K	759.66
Financial Cash Flow	-53K	23.79M	24.76M	25.03M	28.37M	4.59M	3.88M	13.38M	13.01M	13.13M	18.26M	41.9M	46.04M	48.41M	44.28M	11.06M	9.06M	8.08M	6.82M	7.41M	2M	426.39K	469.39K	10.92M	11.08M	11.08M	11.04M	770.90	3.07K	3.83K	4.59K	4.59K	1.52K	759.66
Net Cash Flow	-14.32M	10.31M	13.06M	12.76M	23.32M	-6.6M	-9.84M	153K	-7.5M	15.34M	7.68M	16.26M	22.21M	9.51M	20.33M	2.33M	565.62K	-531.76K	-1.57M	-1.75M	-8.12M	-10.44M	-10.1M	1.21M	4.35M	6.84M	8.82M	-51.51K	-46.86K	-43.13K	-16.09K	4.93K	1.08K	538.98
Free Cash Flow	-13.34M	-13.82M	-12.66M	-13.26M	-16.38M	-21.32M	-23.58M	-22.85M	-20.13M	-17.41M	-15.31M	-15.82M	-13.85M	-8.85M	-8.95M	-8.31M	-8.3M	-8.26M	-8.04M	-9.01M	-10.09M	-10.69M	-10.12M	-9.91M	-6.75M	-4.58M	-2.81M	-52.34K	-51.11K	-48.14K	-21.87K	-844.34	-441.37	-220.68